Research comes out against NICE guidance

Swedish research has suggested that one of the controversial Alzheimer’s drugs currently under investigation by the National Institute for Clinical Excellence (NICE) could be used to treat the disease in all stages as opposed to its present license for use with patients with mild to moderate Alzheimer’s. A report published last month in medical journal…